News & Updates
Filter by Specialty:

NIH study: Semaglutide associated with lower risk of suicidal ideation
11 Jan 2024
byKanas Chan
Semaglutide is associated with a 49─73 percent lower risk of suicidal ideation vs other agents for treatment of obesity and type 2 diabetes mellitus (T2DM), a National Institutes of Health (NIH)─funded study has shown.
NIH study: Semaglutide associated with lower risk of suicidal ideation
11 Jan 2024
Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation
19 Dec 2023
Majority of the patients with heart failure (HF) who have initiated treatment with sodium-glucose cotransporter 2 inhibitor (SGLT2i) show no change in loop diuretic dose, reports a study.